Provided by Tiger Fintech (Singapore) Pte. Ltd.

Karyopharm Therapeutics

4.02
+0.17004.42%
Volume:105.51K
Turnover:425.90K
Market Cap:34.73M
PE:-0.32
High:4.20
Open:3.92
Low:3.89
Close:3.85
Loading ...
May 03, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Major Issues Report

8-K - Current report
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Dec 18, 2020

Major Issues Report

8-K - Current report
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 08, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 01, 2020

Major Issues Report

8-K - Current report
Nov 02, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2020

Major Issues Report

8-K - Current report